Literature DB >> 36109709

Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.

Cheng Liu1,2, Zongguo Yang3, Lei Wang4, Yunfei Lu3, Bozong Tang3, Hui Miao3, Qingnian Xu3, Xiaorong Chen5.   

Abstract

Entities:  

Year:  2022        PMID: 36109709      PMCID: PMC9479289          DOI: 10.1186/s12876-022-02495-4

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   2.847


× No keyword cloud information.

Retraction Note: BMC Gastroenterology (2015) 15:159 10.1186/s12876-015-0380-5

The Editor has retracted this article. After publication, concerns were raised regarding western blot image similarities between Fig. 3C in this article and Fig. 3B in another article with one shared author [1] that was under consideration within a close time frame. Additionally, Figs. 2 and 4 appear to have breaks in the western blot backgrounds. The authors have confirmed that some of the images were composed from different experiments. The authors have been unable to provide the original blots from the experiments reported in this article. The Editor therefore no longer has confidence in the presented data. None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.
  1 in total

1.  Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.

Authors:  Cheng Liu; Xia Yuan; Le Tao; Zhuoan Cheng; Xiuqin Dai; Xia Sheng; Dongying Xue
Journal:  BMC Complement Altern Med       Date:  2015-06-30       Impact factor: 4.782

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.